Pharma lobbying spend on FDA-related issues rises 20% in 2026

Market overview

In response to calls for regulatory stability, pharmaceutical companies will increase lobbying expenditures focused on FDA-related issues by at least 20% in 2026 compared to 2025, as reported by transparency groups.

legal prediction market

Implied probability (Yes)

75%

Source: user-generated

More legal markets

• Will Baviskar's trading accounts be permanently restricted by November 25, 2026? — 95% Yes
• Will Ichcoin Tech Corp. settle with the SEC within 90 days? — 75% Yes
• Will any individual respondent settle with the SEC before year-end 2026? — 30% Yes
• Will the SEC announce a freeze on Ferder's personal assets by November 30, 2026? — 70% Yes
• Will Bonanza Global investors recover more than $1M by November 2026? — 25% Yes
• Will at least one respondent comply with subpoenas within 30 days of court order? — 65% Yes
• Will the court impose a civil penalty on Chavez by 2026-12-01? — 90% Yes
• SEC drops enforcement actions against major crypto exchanges within 12 months — 55% Yes

Browse all legal markets →